Skip to main content
Top
Published in: International Journal for Equity in Health 1/2015

Open Access 01-12-2015 | Research

Barriers in household access to medicines for chronic conditions in three Latin American countries

Authors: Isabel Cristina Martins Emmerick, Vera Lucia Luiza, Luiz Antonio Bastos Camacho, Catherine Vialle-Valentin, Dennis Ross-Degnan

Published in: International Journal for Equity in Health | Issue 1/2015

Login to get access

Abstract

Background

Access to medicines is one of the major challenges in health policy. The high out-of-pocket expenditures on medicines in the Latin American and Caribbean (LAC) region represents important barrier to affordable access to care for NCDs. This paper aim to identify key barriers in access to medicines for household members with a diagnosed chronic condition in three Central America countries.

Methods

This was a cross-sectional analytic study, based on data from three household surveys using a common methodology. We examined associated factors to: (1) seeking care for chronic illness from a trained clinician in the formal health system, and (2) obtaining all medicines sought for the chronic conditions reported.

Results

A chronic condition was reported in 29.8 % (827) of 2761 households - 47.0, 30.7 and 11.8 % in Nicaragua, Honduras and Guatemala, respectively. The three main chronic conditions reported were hypertension, arthritis, and diabetes. Seeking care in the formal health system ranged from 73.4 % in Nicaragua to 83.1 % in Honduras, while full access to medicines varied from 71.6 % in Guatemala to 88.0 % in Honduras. The main associated factors of seeking care in the formal health system were geographic location, household head gender, Spanish literacy, patient age, perceived health status, perceived quality of public sector care, household economic level, and having health insurance. Seeking care in the formal health system was the main bivariate associated factor of obtaining full access to medicines (OR: 4.3 95 % CI 2.6 – 7.0). The odds of full access to medicines were significantly higher when the household head was older than 65 years, medicines were obtained for free, households had higher socioeconomic status, and health care was sought in the private sector.

Conclusions

The nature of the health system plays an important role in access to medicines. Access is better when public facilities are available and function effectively, or when private sector care is affordable. Thus, understanding how people seek care in a given setting and strengthening key health system components will be important strategies to improve access to medicines, especially for populations at high risk of poor access.
Literature
1.
go back to reference Hogerzeil HV, Mirza Z. The world medicines situation 2011: access to essential medicines as part of the right to health. Geneva: World Health Organization; 2011. p. 680–9. Hogerzeil HV, Mirza Z. The world medicines situation 2011: access to essential medicines as part of the right to health. Geneva: World Health Organization; 2011. p. 680–9.
2.
go back to reference WHO (World Health Organization). Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2010. WHO (World Health Organization). Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2010.
3.
go back to reference Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013;381:680–9.CrossRefPubMed Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013;381:680–9.CrossRefPubMed
4.
go back to reference WHO (World Health Organization). Noncommunicable diseases country profiles 2011. 2011. WHO (World Health Organization). Noncommunicable diseases country profiles 2011. 2011.
5.
go back to reference PAHO (Pan American Health Organization). Health in the Americas - regional outlook and country profiles. 2nd ed. Washington, D. C.: Pan American Health Organization, Pan American Sanitary Bureau, Regional Office of the World Health Organization; 2012. PAHO (Pan American Health Organization). Health in the Americas - regional outlook and country profiles. 2nd ed. Washington, D. C.: Pan American Health Organization, Pan American Sanitary Bureau, Regional Office of the World Health Organization; 2012.
6.
go back to reference Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.PubMedCentralCrossRefPubMed Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.PubMedCentralCrossRefPubMed
7.
go back to reference WHO (World Health Organization). Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World Health Organization; 2014. WHO (World Health Organization). Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World Health Organization; 2014.
8.
go back to reference WHO (World Health Organization). Everybody Business: Strengthening Health Systems to Improve Health Outcomes: WHO’s Framework for Action. Geneva; 2007. WHO (World Health Organization). Everybody Business: Strengthening Health Systems to Improve Health Outcomes: WHO’s Framework for Action. Geneva; 2007.
9.
go back to reference Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2012. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2012.
10.
go back to reference Bigdeli M, Peters DH, Wagner AK. Medicines in health systems: advancing access, affordability and appropriate use. 1st ed. Geneve: World Health Organization; 2014. Bigdeli M, Peters DH, Wagner AK. Medicines in health systems: advancing access, affordability and appropriate use. 1st ed. Geneve: World Health Organization; 2014.
11.
go back to reference PAHO (Pan American Health Organization). Impact of exclusion on health care services on access to medicines in Nicaragua, Honduras and Guatemala. Agregate and comparative análisis of the situation. Washington, D.C.: Organização Pan-Americana da Saúde; 2010. PAHO (Pan American Health Organization). Impact of exclusion on health care services on access to medicines in Nicaragua, Honduras and Guatemala. Agregate and comparative análisis of the situation. Washington, D.C.: Organização Pan-Americana da Saúde; 2010.
12.
go back to reference Emmerick ICM, Luiza VL, Camacho LAB, Ross-Degnan D. Access to medicines for acute illness in middle income countries in Central America. Rev Saude Publica. 2013;47:1069–79.PubMedCentralCrossRefPubMed Emmerick ICM, Luiza VL, Camacho LAB, Ross-Degnan D. Access to medicines for acute illness in middle income countries in Central America. Rev Saude Publica. 2013;47:1069–79.PubMedCentralCrossRefPubMed
13.
go back to reference Acuña C, Marin N, Mendoza A, Emmerick ICM, Luiza VL, Azeredo TB. Determinantes sociales de la exclusión a los servicios de salud y a medicamentos en tres países de América Central [Social determinants of exclusion from health services and medicines in three Central American countries]. Rev Panam Salud Publica. 2014;35:128–35.PubMed Acuña C, Marin N, Mendoza A, Emmerick ICM, Luiza VL, Azeredo TB. Determinantes sociales de la exclusión a los servicios de salud y a medicamentos en tres países de América Central [Social determinants of exclusion from health services and medicines in three Central American countries]. Rev Panam Salud Publica. 2014;35:128–35.PubMed
14.
go back to reference PAHO (Pan American Health Organization). Health systems profile in Nicaragua: monitoring and analyzing health systems change/reform. Washington, D. C.: PAHO; 2008. PAHO (Pan American Health Organization). Health systems profile in Nicaragua: monitoring and analyzing health systems change/reform. Washington, D. C.: PAHO; 2008.
15.
go back to reference PAHO (Pan American Health Organization). Health System Profile Honduras, Central America: Monitoring and Analysis of Health Systems Change/Reform. Washington, D.C.; 2009. PAHO (Pan American Health Organization). Health System Profile Honduras, Central America: Monitoring and Analysis of Health Systems Change/Reform. Washington, D.C.; 2009.
16.
go back to reference PAHO (Pan American Health Organization). Health Systems Profile of Guatemala. Washington, D.C; 2007. PAHO (Pan American Health Organization). Health Systems Profile of Guatemala. Washington, D.C; 2007.
17.
go back to reference MSPAS-Guatemala (Ministerio de Salud Pública y Asistencia Social de Guatemala), OPS/OMS (Organización Panamericana de la Salud/Organización Mundial de la Salud): Perfil Farmacéutico de La República de Guatemala. 2012. MSPAS-Guatemala (Ministerio de Salud Pública y Asistencia Social de Guatemala), OPS/OMS (Organización Panamericana de la Salud/Organización Mundial de la Salud): Perfil Farmacéutico de La República de Guatemala. 2012.
18.
go back to reference SES-ES (Secretaria Estadual de Saúde do Espírito Santo). Diagnóstico Da Assistência Farmacêutica No Setor Público E a Política Farmacêutica Do Estado Do Espírito Santo. Vitória - Espírito Santo - Brasil: Secretaria de Estado da Saúde. Gerência de Assistência Farmacêutica; 2007. SES-ES (Secretaria Estadual de Saúde do Espírito Santo). Diagnóstico Da Assistência Farmacêutica No Setor Público E a Política Farmacêutica Do Estado Do Espírito Santo. Vitória - Espírito Santo - Brasil: Secretaria de Estado da Saúde. Gerência de Assistência Farmacêutica; 2007.
19.
go back to reference MoH-Oman (Ministry of Health of Oman). Household Survey on Medicine Use in Oman. Directorate of Rational Use of Medicines Ministry of Health Muscat, Sultanate of Oman; 2009. MoH-Oman (Ministry of Health of Oman). Household Survey on Medicine Use in Oman. Directorate of Rational Use of Medicines Ministry of Health Muscat, Sultanate of Oman; 2009.
20.
go back to reference Batangan DB, Juban N. Philippines Pharmaceutical Situation 2009 WHO Household Survey on Medicines. World Health Organization, Manila 2009. Batangan DB, Juban N. Philippines Pharmaceutical Situation 2009 WHO Household Survey on Medicines. World Health Organization, Manila 2009.
21.
go back to reference Arhinful DK. Who Level II Household Survey to Measure Access to and Use of Medicines in Ghana. Ministry of Health Ghana, Ghana. 2010. Arhinful DK. Who Level II Household Survey to Measure Access to and Use of Medicines in Ghana. Ministry of Health Ghana, Ghana. 2010.
22.
go back to reference FMoH-Nigeria (Federal Ministry of Health Nigeria). Access to and Rational Use of Medicines at the Household Level. Federal Ministry of Health, Nigeria; 2010. FMoH-Nigeria (Federal Ministry of Health Nigeria). Access to and Rational Use of Medicines at the Household Level. Federal Ministry of Health, Nigeria; 2010.
23.
go back to reference Bruce N, Pope D, Arana B, Shiels C, Romero C, Klein R, et al. Determinants of care seeking for children with pneumonia and diarrhea in Guatemala: implications for intervention strategies. Am J Public Health. 2014;104:647–57.CrossRefPubMed Bruce N, Pope D, Arana B, Shiels C, Romero C, Klein R, et al. Determinants of care seeking for children with pneumonia and diarrhea in Guatemala: implications for intervention strategies. Am J Public Health. 2014;104:647–57.CrossRefPubMed
24.
go back to reference OPS/OMS (Organização Pan-Americana da Saúde/Organização Mundial da Saúde), MS-Brasil (Ministério da Saúde do Brasil). Avaliação Da Assistência Farmacêutica No Brasil: Estrutura, Processo E Resultados. Brasília - Distrito Federal: Organização Pan-Americana da Saúde/Organização Mundial da Saúde; Ministério da Saúde; 2005. OPS/OMS (Organização Pan-Americana da Saúde/Organização Mundial da Saúde), MS-Brasil (Ministério da Saúde do Brasil). Avaliação Da Assistência Farmacêutica No Brasil: Estrutura, Processo E Resultados. Brasília - Distrito Federal: Organização Pan-Americana da Saúde/Organização Mundial da Saúde; Ministério da Saúde; 2005.
25.
go back to reference Leyva-Flores R, Erviti-Erice J, Kageyama-Escobar MDELALUZ, Arredondo A. Prescripción, acceso y gasto en medicamentos entre usuarios de servicios de salud en México. Salud Pública México. 1998;40:24–31.CrossRef Leyva-Flores R, Erviti-Erice J, Kageyama-Escobar MDELALUZ, Arredondo A. Prescripción, acceso y gasto en medicamentos entre usuarios de servicios de salud en México. Salud Pública México. 1998;40:24–31.CrossRef
26.
go back to reference Paniz VM, Fassa AG, Facchini LA, Bertoldi AD, Piccini RX, Tomasi E, et al. Access to continuous-use medication among adults and the elderly in South and Northeast Brazil. Cad Saude Publica. 2008;24:267–80.CrossRefPubMed Paniz VM, Fassa AG, Facchini LA, Bertoldi AD, Piccini RX, Tomasi E, et al. Access to continuous-use medication among adults and the elderly in South and Northeast Brazil. Cad Saude Publica. 2008;24:267–80.CrossRefPubMed
27.
go back to reference Zambrano A, Ramírez M, Yepes FJ, Guerra JA, Rivera D. Qué muestran las Encuestas de Calidad de Vida sobre el sistema de salud en Colombia? What do living standard surveys show about the health system in Colombia? Cad Saude Publica. 2008;24:122–30.CrossRefPubMed Zambrano A, Ramírez M, Yepes FJ, Guerra JA, Rivera D. Qué muestran las Encuestas de Calidad de Vida sobre el sistema de salud en Colombia? What do living standard surveys show about the health system in Colombia? Cad Saude Publica. 2008;24:122–30.CrossRefPubMed
28.
go back to reference OPS/OMS (Organización Panamericana de la Salud - Organización Mundial de la Salud): Exclusión En Salud En Países de América Latina Y El Caribe. Washington DC; 2004. OPS/OMS (Organización Panamericana de la Salud - Organización Mundial de la Salud): Exclusión En Salud En Países de América Latina Y El Caribe. Washington DC; 2004.
29.
30.
go back to reference Boing AC, Bertoldi AD, Boing AF, Bastos JL, Peres KG. Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil. Cad Saude Publica. 2011;29:691–701.CrossRef Boing AC, Bertoldi AD, Boing AF, Bastos JL, Peres KG. Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil. Cad Saude Publica. 2011;29:691–701.CrossRef
31.
go back to reference Wagner AK, Graves AJ, Reiss SK, LeCates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey. Health Policy. 2011;100:151–8.CrossRefPubMed Wagner AK, Graves AJ, Reiss SK, LeCates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey. Health Policy. 2011;100:151–8.CrossRefPubMed
32.
go back to reference Reis AL d A d, Bermudez JAZ. In: Bermudez JAZ, Oliveira MA, Esher Â, editors. Aspectos econômicos: mercado farmacêutico e preços de medicamentos. Rio de Janeiro: ENSP; 2004. Reis AL d A d, Bermudez JAZ. In: Bermudez JAZ, Oliveira MA, Esher Â, editors. Aspectos econômicos: mercado farmacêutico e preços de medicamentos. Rio de Janeiro: ENSP; 2004.
33.
go back to reference Torres Guerra S, Gutiérrez JP. The pharmaceutical market in Mexico: size, value, and concentration. Rev Panam Salud Publica. 2009;26:46–50.CrossRefPubMed Torres Guerra S, Gutiérrez JP. The pharmaceutical market in Mexico: size, value, and concentration. Rev Panam Salud Publica. 2009;26:46–50.CrossRefPubMed
34.
go back to reference Fang K, Jiang Y, Shia B, Ma S. Impact of illness and medical expenditure on household consumptions: a survey in Western China. PLoS One. 2012;7. Fang K, Jiang Y, Shia B, Ma S. Impact of illness and medical expenditure on household consumptions: a survey in Western China. PLoS One. 2012;7.
36.
go back to reference Van Minh H, Xuan Tran B. Assessing the household financial burden associated with the chronic non-communicable diseases in a rural district of Vietnam. Glob Health Action. 2012;5. Van Minh H, Xuan Tran B. Assessing the household financial burden associated with the chronic non-communicable diseases in a rural district of Vietnam. Glob Health Action. 2012;5.
37.
go back to reference Rosenberg H, Andersson B. Repensar la protección social en salud en América Latina y el Caribe. Rev Panam Salud Publica. 2000. Rosenberg H, Andersson B. Repensar la protección social en salud en América Latina y el Caribe. Rev Panam Salud Publica. 2000.
38.
go back to reference de Tejada SS. Manejo de las infecciones respiratorias agudas (IRA) en una comunidad kaqchiquel de Guatemala. Pan Am J Public Health. 1997. de Tejada SS. Manejo de las infecciones respiratorias agudas (IRA) en una comunidad kaqchiquel de Guatemala. Pan Am J Public Health. 1997.
39.
go back to reference Hautecoeur M, Zunzunegui MV, Vissandjee B. Las barreras de acceso a los servicios de salud en la población indígena de Rabinal en Guatemala. Salud Pública México. 2007;49. Hautecoeur M, Zunzunegui MV, Vissandjee B. Las barreras de acceso a los servicios de salud en la población indígena de Rabinal en Guatemala. Salud Pública México. 2007;49.
40.
go back to reference Mendonza-Sassi R, Béria JU. Utilización de los servicios de salud: una revisión sistemática sobre los factores relacionados. Cuad Med Soc. 2001;81:43–60. Mendonza-Sassi R, Béria JU. Utilización de los servicios de salud: una revisión sistemática sobre los factores relacionados. Cuad Med Soc. 2001;81:43–60.
41.
go back to reference Arrais PSD, Brito LL, Barreto ML, Coelho HLL. Prevalência e fatores determinantes do consumo de medicamentos no Município de Fortaleza, Ceará, Brasil. Cad Saude Publica. 2005;21:1737–46.CrossRefPubMed Arrais PSD, Brito LL, Barreto ML, Coelho HLL. Prevalência e fatores determinantes do consumo de medicamentos no Município de Fortaleza, Ceará, Brasil. Cad Saude Publica. 2005;21:1737–46.CrossRefPubMed
42.
go back to reference Bertoldi AD, de Barros AJD, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2009;89:295–302.CrossRefPubMed Bertoldi AD, de Barros AJD, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2009;89:295–302.CrossRefPubMed
43.
go back to reference Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012;2. Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012;2.
44.
go back to reference Adamson J, Ben-Shlomo Y, Chaturvedi N, Donovan J. Ethnicity, socio-economic position and gender do they affect reported health care seeking behaviour? Soc Sci Med. 2003;57:895–904.CrossRefPubMed Adamson J, Ben-Shlomo Y, Chaturvedi N, Donovan J. Ethnicity, socio-economic position and gender do they affect reported health care seeking behaviour? Soc Sci Med. 2003;57:895–904.CrossRefPubMed
45.
go back to reference Travassos C, Martins M. Uma revisão sobre os conceitos de acesso e utilização de serviços de saúde. Cad Saude Publica. 2004;20(Sup 2):S190–8.PubMed Travassos C, Martins M. Uma revisão sobre os conceitos de acesso e utilização de serviços de saúde. Cad Saude Publica. 2004;20(Sup 2):S190–8.PubMed
46.
go back to reference Pavão ALB, Werneck GL, Campos MR. Self-rated health and the association with social and demographic factors, health behavior, and morbidity: a national health survey. Cad Saude Publica. 2013;29:723–34.CrossRefPubMed Pavão ALB, Werneck GL, Campos MR. Self-rated health and the association with social and demographic factors, health behavior, and morbidity: a national health survey. Cad Saude Publica. 2013;29:723–34.CrossRefPubMed
47.
go back to reference Scheppers E, Van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23:325–48.CrossRefPubMed Scheppers E, Van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23:325–48.CrossRefPubMed
48.
go back to reference WHO (World Health Organization). Equitable access to essential medicines: a framework for collective action. Policy Perspect Med. 2004;8:1–6. WHO (World Health Organization). Equitable access to essential medicines: a framework for collective action. Policy Perspect Med. 2004;8:1–6.
49.
go back to reference Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008;373:240–9.CrossRefPubMed Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008;373:240–9.CrossRefPubMed
50.
go back to reference Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412–21.PubMedCentralCrossRefPubMed Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011;89:412–21.PubMedCentralCrossRefPubMed
Metadata
Title
Barriers in household access to medicines for chronic conditions in three Latin American countries
Authors
Isabel Cristina Martins Emmerick
Vera Lucia Luiza
Luiz Antonio Bastos Camacho
Catherine Vialle-Valentin
Dennis Ross-Degnan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2015
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/s12939-015-0254-z

Other articles of this Issue 1/2015

International Journal for Equity in Health 1/2015 Go to the issue